Bioprocessing Summit Europe
Date: March 10-12, 2026
Location: InterContinental Barcelona, Spain
JOIN US!
Catalent accelerates biologics development with high‑titer cell line development, advanced analytical strategies, integrated Gene‑to‑GMP capabilities, and end‑to‑end drug product fill‑finish solutions. Meet with our team in Barcelona to learn how we streamline upstream, downstream, analytical, and fill‑finish workflows to advance next‑generation molecules with greater speed and confidence.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Speaker: Larry Anderson, Senior Group Leader, Analytical Development
Date/Time: Wednesday March 11th 2026 – 10:00am in the Accelerating Analytical Development Track
Title: High Throughput Strategies to Accelerate Analytical Method Development: From In-Process Monitoring to GMP
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
